Enorama Pharma AB (ERMA) — Net Asset Quality Index
Enorama Pharma AB (ERMA) has a Net Asset Quality Index of -159.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr22.95 Million minus total liabilities of Skr59.58 Million yields net assets of Skr-36.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Enorama Pharma AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enorama Pharma AB Net Asset Quality Index Over Time (2014–2025)
This chart shows how Enorama Pharma AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the index stands at -159.6%, representing net assets of Skr-36.63 Million against total assets of Skr22.95 Million SEK. Explore cash flow conversion of Enorama Pharma AB to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Enorama Pharma AB (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Enorama Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Enorama Pharma AB market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -283.8% | Skr-23.45 Million | Skr8.26 Million | Skr31.71 Million | ▼ -332.9 pp |
| 2024 | 49.1% | Skr7.80 Million | Skr15.89 Million | Skr8.09 Million | ▼ -7.7 pp |
| 2023 | 56.8% | Skr19.54 Million | Skr34.38 Million | Skr14.85 Million | ▼ -7.9 pp |
| 2022 | 64.7% | Skr31.52 Million | Skr48.72 Million | Skr17.20 Million | ▲ +22.8 pp |
| 2021 | 41.9% | Skr21.35 Million | Skr50.93 Million | Skr29.58 Million | ▲ +37.6 pp |
| 2020 | 4.3% | Skr1.78 Million | Skr40.91 Million | Skr39.13 Million | ▼ -12.5 pp |
| 2019 | 16.9% | Skr7.18 Million | Skr42.58 Million | Skr35.40 Million | ▼ -27.0 pp |
| 2018 | 43.8% | Skr17.02 Million | Skr38.83 Million | Skr21.81 Million | ▼ -3.7 pp |
| 2017 | 47.5% | Skr7.36 Million | Skr15.49 Million | Skr8.13 Million | ▼ -19.1 pp |
| 2016 | 66.6% | Skr9.08 Million | Skr13.63 Million | Skr4.55 Million | ▼ -4.5 pp |
| 2015 | 71.2% | Skr6.52 Million | Skr9.17 Million | Skr2.64 Million | ▼ -0.8 pp |
| 2014 | 72.0% | Skr2.66 Million | Skr3.69 Million | Skr1.03 Million | — |